A consistent downregulation of CHK1, CHK2, CDK6, and Cyclin D1 was observed, which confirms that cell cycle arrest at the G2/GM phase could be substantial for Lanatoside C treatment to cancer cells. Here, CHEK2 is linked to cancer.